128 related articles for article (PubMed ID: 2962734)
21. The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
Demers LM; Melby JC; Wilson TE; Lipton A; Harvey HA; Santen RJ
J Clin Endocrinol Metab; 1990 Apr; 70(4):1162-6. PubMed ID: 2156889
[TBL] [Abstract][Full Text] [Related]
22. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
Brueggemeier RW; Li PK
Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
[TBL] [Abstract][Full Text] [Related]
23. Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
Purba HS; King EJ; Richert P; Bhatnagar AS
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):215-9. PubMed ID: 8142297
[TBL] [Abstract][Full Text] [Related]
24. Potency and specificity of CGS-16949A as an aromatase inhibitor.
Santen RJ; Langecker P; Santner SJ; Sikka S; Rajfer J; Swerdloff R
Endocr Res; 1990; 16(1):77-91. PubMed ID: 2139412
[TBL] [Abstract][Full Text] [Related]
25. Fourteen-day oral combination dose toxicity study of CGS 16949 A (aromatase inhibitor) with 5-fluorouracil or tamoxifen in rats.
Matsuda A; Higuchi K; Karasawa M; Yoneyama S; Deguchi J; Miyamoto M
J Toxicol Sci; 1997 Feb; 22(1):1-24. PubMed ID: 9076654
[TBL] [Abstract][Full Text] [Related]
26. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Sugamata N; Koibuchi Y; Iino Y; Morishita Y
Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
[TBL] [Abstract][Full Text] [Related]
27. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
28. Evidence that corticosterone is not an obligatory intermediate in aldosterone biosynthesis in the rat adrenal.
Häusler A; Monnet G; Borer C; Bhatnagar AS
J Steroid Biochem; 1989; 34(1-6):567-70. PubMed ID: 2533953
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.
Schieweck K; Bhatnagar AS; Batzl C; Lang M
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):633-6. PubMed ID: 8476774
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
31. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
32. [Introduction of a new aromatase inhibitor fadrozole hydrochloride hydsate].
Tsukagoshi S
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1991-7. PubMed ID: 7487133
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C
Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824
[TBL] [Abstract][Full Text] [Related]
34. Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin.
Cho-Chung YS; Clair T; Shepheard C; Berghoffer B
Cancer Res; 1983 Apr; 43(4):1473-6. PubMed ID: 6299521
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
Matsuzawa A; Mizuno Y; Yamamoto T
Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
[TBL] [Abstract][Full Text] [Related]
36. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
37. Effects of nonsteroidal antiestrogens, analog II and tamoxifen, on a metastatic transplantable rat mammary tumor.
King MM; Magarian RA; Terao J; Brueggemann GL
J Natl Cancer Inst; 1985 Feb; 74(2):447-51. PubMed ID: 3919197
[TBL] [Abstract][Full Text] [Related]
38. A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
Tekmal RR; Durgam VR
Cancer Lett; 1997 Sep; 118(1):21-8. PubMed ID: 9310256
[TBL] [Abstract][Full Text] [Related]
39. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
Fendl KC; Zimniski SJ
Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
[TBL] [Abstract][Full Text] [Related]
40. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
